DIA
ZBH icon

Dean Investment Associates’s Zimmer Biomet ZBH Stock Holding History

Dean Investment Associates’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.39M Buy
48,584
+11,818
+32% +$1.08M 0.62% 69
2025
Q4 		$3.31M Buy
36,766
+2,485
+7% +$236K 0.47% 109
2025
Q3 		$3.38M Buy
34,281
+2,062
+6% +$204K 0.47% 106
2025
Q2 		$2.94M Buy
32,219
+1,407
+5% +$136K 0.43% 117
2025
Q1 		$3.49M Buy
30,812
+1,559
+5% +$167K 0.52% 79
2024
Q4 		$3.09M Buy
29,253
+4,866
+20% +$522K 0.44% 96
2024
Q3 		$2.63M Buy
24,387
+2,868
+13% +$313K 0.36% 143
2024
Q2 		$2.34M Buy
21,519
+6,792
+46% +$801K 0.33% 143
2024
Q1 		$1.94M Buy
14,727
+515
+4% +$64.3K 0.27% 156
2023
Q4 		$1.73M Buy
14,212
+790
+6% +$88.2K 0.25% 164
2023
Q3 		$1.51M Buy
13,422
+3,046
+29% +$387K 0.25% 166
2023
Q2 		$1.51M Sell
10,376
-286
-3% -$38.9K 0.25% 149
2023
Q1 		$1.38M Sell
10,662
-209
-2% -$26.2K 0.22% 158
2022
Q4 		$1.39M Buy
10,871
+778
+8% +$90.3K 0.24% 146
2022
Q3 		$1.05M Sell
10,093
-155
-2% -$17K 0.22% 172
2022
Q2 		$1.08M Buy
10,248
+32
+0.3% +$3.8K 0.21% 183
2022
Q1 		$1.31M Buy
10,216
+900
+10% +$108K 0.23% 169
2021
Q4 		$1.15M Sell
9,316
-604
-6% -$79K 0.2% 183
2021
Q3 		$1.41M Buy
9,920
+864
+10% +$127K 0.27% 159
2021
Q2 		$1.41M Sell
9,056
-84
-0.9% -$13.6K 0.26% 171
2021
Q1 		$1.42M Buy
9,140
+1,164
+15% +$180K 0.27% 172
2020
Q4 		$1.19M Buy
7,976
+533
+7% +$75.3K 0.25% 184
2020
Q3 		$984K Sell
7,443
-688
-8% -$89.9K 0.24% 169
2020
Q2 		$942K Buy
8,131
+37
+0.5% +$4.26K 0.23% 151
2020
Q1 		$794K Sell
8,094
-344
-4% -$45.1K 0.17% 170
2019
Q4 		$1.23M Buy
8,438
+21
+0.2% +$2.9K 0.19% 160
2019
Q3 		$1.12M Buy
8,417
+51
+0.6% +$6.59K 0.16% 158
2019
Q2 		$956K Buy
8,366
+61
+0.7% +$7.14K 0.14% 166
2019
Q1 		$1.03M Buy
8,305
+333
+4% +$37.8K 0.15% 158
2018
Q4 		$803K Buy
7,972
+83
+1% +$9.33K 0.13% 164
2018
Q3 		$1.01M Buy
7,889
+174
+2% +$20.7K 0.14% 153
2018
Q2 		$835K Buy
7,715
+1,201
+18% +$131K 0.12% 168
2018
Q1 		$690K Buy
6,514
+157
+2% +$18.2K 0.1% 190
2017
Q4 		$745K Buy
6,357
+253
+4% +$28.6K 0.11% 187
2017
Q3 		$694K Buy
6,104
+64
+1% +$7.39K 0.11% 180
2017
Q2 		$753K Buy
6,040
+204
+3% +$24.2K 0.11% 155
2017
Q1 		$692K Buy
5,836
+301
+5% +$34.1K 0.12% 161
2016
Q4 		$555K Buy
5,535
+1,151
+26% +$123K 0.1% 191
2016
Q3 		$553K Buy
4,384
+40
+0.9% +$4.94K 0.1% 159
2016
Q2 		$508K Sell
4,344
-7
-0.2% -$792 0.1% 168
2016
Q1 		$450K Buy
4,351
+197
+5% +$19.1K 0.09% 191
2015
Q4 		$414K Sell
4,154
-106
-2% -$10.4K 0.09% 194
2015
Q3 		$388K Sell
4,260
-64
-1% -$6.42K 0.09% 201
2015
Q2 		$459K Hold
4,324
– – 0.1% 203
2015
Q1 		$493K Buy
4,324
+106
+3% +$12.1K 0.11% 182
2014
Q4 		$464K Sell
4,218
-417
-9% -$44K 0.11% 187
2014
Q3 		$452K Sell
4,635
-16
-0.3% -$1.57K 0.11% 189
2014
Q2 		$469K Sell
4,651
-99
-2% -$9.66K 0.11% 190
2014
Q1 		$436K Buy
4,750
+68
+1% +$6.27K 0.1% 189
2013
Q4 		$424K Buy
4,682
+67
+1% +$5.8K 0.1% 188
2013
Q3 		$368K Buy
4,615
+27
+0.6% +$2.13K 0.1% 192
2013
Q2 		$334K Buy
+4,588
New +$343K 0.1% 195

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dean Investment Associates's ZBH Position: Q1 2026 in Review

Dean Investment Associates increased its Zimmer Biomet (ZBH) stake by 32% in Q1 2026, buying an estimated $1.08M and bringing the position to 48,584 shares worth $4.39M. The position accounts for 0.62% of the portfolio, ranked #69.

Dean Investment Associates first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Dean Investment Associates held 48,584 shares of Zimmer Biomet worth $4.39M as of Q1 2026.
  • Dean Investment Associates bought 11,818 Zimmer Biomet shares in Q1 2026, an estimated $1.08M.
  • Zimmer Biomet made up 0.62% of Dean Investment Associates's portfolio in Q1 2026, its #69 holding.
  • Dean Investment Associates first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Dean Investment Associates's 13F filing for Q1 2026, filed 15 May 2026.